Status:
COMPLETED
Decoding Risks and Rewards in Ischemic Stroke Surgery
Lead Sponsor:
China Medical University Hospital
Conditions:
Ischemic Stroke
Eligibility:
All Genders
20+ years
Brief Summary
In the high-stakes battle against ischemic cerebrovascular disease, where every second counts and the margin for error is slim, how do the investigators tip the scales in favor of patient survival and...
Eligibility Criteria
Inclusion
- \- All participants underwent either a computed tomography (CT) scan or magnetic resonance imaging (MRI) within two days before or after hospital admission.
- The date of the first ischemic stroke hospitalization served as the index event.
- Among these patients, those who underwent surgical interventions post-hospitalization were categorized into three distinct groups: CEA (ICD-9-CM code 3812), CAS (ICD-9-CM code 3990), and EC-IC (ICD-9-CM code 3928), with the operation date being the index date.
- Those who did not receive any surgical interventions were considered the non-intervention control group and had their first hospitalization date as the index date.
Exclusion
- \- patients with a history of: any stroke subtype (ICD-9-CM codes 430-434), Moyamoya disease (ICD-9-CM code 437.5), cancer (ICD-9-CM codes 140-239), trauma (various ICD-9-CM codes), transient ischemic attack (ICD-9-CM code 435), unruptured cerebral aneurysm (ICD-9-CM code 437.3), or subarachnoid hemorrhage (ICD-9-CM code 430).
Key Trial Info
Start Date :
May 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 31 2023
Estimated Enrollment :
204411 Patients enrolled
Trial Details
Trial ID
NCT06098066
Start Date
May 1 2020
End Date
January 31 2023
Last Update
October 24 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
China Medical University Hospital
Taichung, Taiwan